How severe is CVE-2005-3027?

CVE-2005-3027 has a CVSS 2.0 base score of 5.0, rated medium severity.

Is CVE-2005-3027 being actively exploited?

It is not currently listed in CISA's KEV catalog. Its EPSS exploit-prediction score is 2% (72nd percentile), an estimate of the probability of exploitation in the next 30 days.

What products are affected by CVE-2005-3027?

CVE-2005-3027 primarily affects Sybari Antigen. In total, 2 product configurations (CPEs) are listed as vulnerable; see the affected-products list for the exact versions.

How do I fix CVE-2005-3027?

Review the linked vendor and NVD advisories for patched versions and mitigations, then upgrade or apply the recommended workaround.

When was CVE-2005-3027 published?

CVE-2005-3027 was published on 2005-09-21 and last updated on 2026-06-16.

CVE-2005-3027

CVE-2005-3027 is a medium-severity vulnerability in Sybari Antigen with a CVSS 2.0 base score of 5.0. It is not currently listed as actively exploited by CISA, and its EPSS exploit-prediction score is low.

Key facts

Severity: Medium (CVSS 2.0 base score 5.0)
EPSS exploit prediction: 2% (72nd percentile)
Actively exploited: Not listed in CISA KEV
Affected product: Sybari Antigen
Published: 2005-09-21
Last modified: 2026-06-16

Description

Sybari Antigen 8.0 SR2 does not properly filter SMTP messages, which allows remote attackers to bypass custom filter rules and send file attachments of arbitrary file types via a message with a subject of "Antigen forwarded attachment".

Frequently asked questions

What is CVE-2005-3027?: Sybari Antigen 8.0 SR2 does not properly filter SMTP messages, which allows remote attackers to bypass custom filter rules and send file attachments of arbitrary file types via a message with a subject of "Antigen forwarded attachment".
How severe is CVE-2005-3027?: CVE-2005-3027 has a CVSS 2.0 base score of 5.0, rated medium severity.
Is CVE-2005-3027 being actively exploited?: It is not currently listed in CISA's KEV catalog. Its EPSS exploit-prediction score is 2% (72nd percentile), an estimate of the probability of exploitation in the next 30 days.
What products are affected by CVE-2005-3027?: CVE-2005-3027 primarily affects Sybari Antigen. In total, 2 product configurations (CPEs) are listed as vulnerable; see the affected-products list for the exact versions.
How do I fix CVE-2005-3027?: Review the linked vendor and NVD advisories for patched versions and mitigations, then upgrade or apply the recommended workaround.
When was CVE-2005-3027 published?: CVE-2005-3027 was published on 2005-09-21 and last updated on 2026-06-16.

References

Affected products (2)

cpe:2.3:a:sybari:antigen:8.0:sr2:exchange:*:*:*:*:*
cpe:2.3:a:sybari:antigen:8.0:sr2:smtp_gateways:*:*:*:*:*

More vulnerabilities in Sybari Antigen

CVE-2004-2348 — Medium (CVSS 5.0): Sybari AntiGen for Domino 7.0 Build 722 SR2 allows remote attackers to cause a denial of service (hang) via an…

All CVEs affecting Sybari Antigen →